Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Gold-nanofeve surface-enhanced Raman spectroscopy visualizes hypotaurine as a robust anti-oxidant consumed in cancer survival
Rapid and Effective Results: Witness the transformation of your skin in just a few days
Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer
Nausea, flushing, libido changes, and blood pressure symptoms should be interpreted with medication context
How to conduct a bibliometric analysis: an overview and guidelines
Roche will no longer invest in the development of acmopatide, previously known as CT-868, the pharma revealed in an investor presentation on Tuesday alongside its second quarter earnings report
US$ 23.67
US$ 28.75
US$ 20.49
US$ 29.48
